智通财经APP讯，东方生物(688298.SH)发布公告，公司及下属全资子公司美国衡健生物科技有限公司(以下简称“美国衡健”)、上海万子健生物科技有限公司(以下简称“上海万子健”)近期取得多项产品的国内外医疗器械注册证。
上述产品在国内外市场取证，丰富了公司产品布局，有利于整体市场拓展。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.